KAINOS Laboratories, Inc. (4556.T)

JPY 1238.0

(0.73%)

Annual Balance Sheets

(In JPY)
Breakdown 2024 2023 2022 2021 2020
Total Assets 8.59 Billion 8.11 Billion 7.57 Billion 6.96 Billion 6.74 Billion
Total Current Assets 5.69 Billion 5.21 Billion 4.69 Billion 4.05 Billion 3.8 Billion
Cash And Short Term Investments 3.17 Billion 3.01 Billion 2.67 Billion 2.24 Billion 1.96 Billion
Cash and Cash Equivalents 3.17 Billion 3.01 Billion 2.67 Billion 2.24 Billion 1.62 Billion
Short Term Investments 340 Million -19 Million -18.47 Million -18.46 Million 340 Million
Net Receivables 1.57 Billion 1.42 Billion 1.33 Billion 1.21 Billion 1.2 Billion
Inventory 879.01 Million 749.44 Million 647.59 Million 576.44 Million 608.14 Million
Other Current Assets 64.86 Million 25.98 Million 26.4 Million 23.99 Million 32.39 Million
Total Non-Current Assets 2.89 Billion 2.89 Billion 2.88 Billion 2.9 Billion 379 Thousand
Net PPE 2.5 Billion 2.54 Billion 2.53 Billion 2.53 Billion 2.53 Billion
Good Will And Intangible Assets 17.43 Million 31.11 Million 57.1 Million 97.53 Million -2.78 Billion
Good Will - - - - -
Intangible Assets 17.43 Million 31.11 Million 57.1 Million 97.53 Million -
Long-Term Investments 218.78 Million 186.82 Million 173.02 Million 175.11 Million 132.07 Million
Tax Assets 136 Million 131.36 Million 115.46 Million 99.5 Million 109.49 Million
Other Non Current Assets 19.35 Million 390 Thousand 769 Thousand 769 Thousand 379 Thousand
Other Assets 3000.00 3000.00 4000.00 2000.00 2.93 Billion
Total Liabilities 2.32 Billion 2.44 Billion 2.37 Billion 2.3 Billion 2.36 Billion
Total Current Liabilities 1.98 Billion 1.91 Billion 1.78 Billion 1.89 Billion 1.84 Billion
Account Payables 528.62 Million 448.18 Million 536.11 Million 440.27 Million 495.55 Million
Tax Payables 203.29 Million 217.56 Million 212.56 Million 174.57 Million 142.49 Million
Short Term Debt 563.95 Million 480.38 Million 412.17 Million 637.43 Million 534.35 Million
Deferred Revenue 881.04 Million 979.56 Million 824.6 Million 808.88 Million 142.49 Million
Other Current Liabilities 6.8 Million 7.95 Million 8.24 Million 7.27 Million 675.7 Million
Total Non Current Liabilities 344.27 Million 529.91 Million 590.25 Million 408.96 Million 515.05 Million
Long-Term Debt 299 Million 460.7 Million 535.43 Million 364.68 Million 400 Million
Deferred Revenue Non Current -14.59 Million - - - -
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities 45.26 Million 69.21 Million 54.82 Million 44.27 Million 115.05 Million
Other Liabilities - - - - 1.00
Total Equity 6.26 Billion 5.66 Billion 5.2 Billion 4.65 Billion 4.38 Billion
Stock Holders Equity 6.26 Billion 5.66 Billion 5.2 Billion 4.65 Billion 4.38 Billion
Common Stock 831.41 Million 831.41 Million 831.41 Million 831.41 Million 831.41 Million
Retained Earnings 4.38 Billion 3.86 Billion 3.4 Billion 2.95 Billion 2.41 Billion
Accumulated other comprehensive income 546.44 Million 498.44 Million 485.86 Million 484.4 Million 466.62 Million
Common Stock Equity 6.26 Billion 5.66 Billion 5.2 Billion 4.65 Billion 4.38 Billion
Capital Lease Obligation 72.96 Million 101.09 Million 67.6 Million 102.11 Million 80.18 Million
Total Investments 218.78 Million 167.82 Million 154.54 Million 156.65 Million 472.07 Million
Total Debt 862.96 Million 941.09 Million 947.6 Million 1 Billion 1.01 Billion
Net Debt -2.31 Billion -2.07 Billion -1.72 Billion -1.24 Billion -609.7 Million

Balance Sheet Charts